Mircera

Roche Holding AG makes a similar drug called Mircera, and the company is locked in a court battle with Amgen over whether it will be able to market it in the U.S.

FDA Panel Backs Curbs on Anemia Drugs 2008

Roche Holding AG makes a similar drug called Mircera, and the company is locked in a court battle with Amgen over whether it will be able to market it in the U.S.

New Anemia-Drug Restrictions Possible 2008

Roche had marketed CERA under the brand name Mircera, and intended it for use by patients with kidney disease to boost the production of oxygen-carrying red blood cells.

The Seattle Times 2010

Mircera, the brand name for CERA made by Swiss-based Roche Holdings, helps users produce more red blood cells, company spokeswoman Claudia Schmitt said.

Cavendish wins fourth stage; Evans stays in yellow 2008

The case continues from last year, when a jury concluded that Mircera infringes numerous patents protecting Amgen's anemia drugs Aranesp and Epogen.

Roche to Increase Royalty 2008

District Court for Massachusetts to grant a permanent injunction barring Roche from selling Mircera in the U.S.

Roche to Increase Royalty 2008

I can only imagine how dangerously high it would be if I ever took Epogen or Mircera.

Digging Deep: Turning a Positive Into a Positive BikeSnobNYC 2008

The U.S. Food and Drug Administration has approved Mircera for sale, but the legal dispute has kept Roche off the market.

Roche to Increase Royalty 2008

Among the court's conditions, Roche will pay Amgen a royalty of 22.5% on sales of Mircera.

Roche to Increase Royalty 2008

To Amgen for Anemia Drug Still hoping to get its anemia drug Mircera onto the U.S. market despite a legal challenge from Amgen Inc.,

Roche to Increase Royalty 2008